Controlled Substance Monitoring and Drugs of Abuse Testing
J9 · Effective Oct 11, 2015
73 active Medicare policies list F20.0, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 11, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Aug 3, 2020
JE · Effective Aug 17, 2020
JF · Effective Aug 17, 2020
JJ · Effective Jul 26, 2020
JM · Effective Jul 26, 2020
J5 · Effective Jul 26, 2020
9 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of F20.0 |
|---|---|---|
| Actigraphy and Accelerometry | Oct 3, 2023 | Covered |
| Electroconvulsive Therapy | Sep 21, 2023 | Covered |
| Hemodialysis for Schizophrenia | May 5, 2023 | Covered |
| Quantitative EEG (Brain Mapping) | Apr 25, 2023 | Covered |
| Quantitative, Functional and Connectomic Analysis of Brain MRI | Oct 4, 2023 | Covered |
| Stereotactic Cingulotomy and Capsulotomy | May 5, 2023 | Covered |
J8 · Effective Jul 26, 2020
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
JJ · Effective Oct 20, 2024
JM · Effective Oct 20, 2024
J6 · Effective Jul 13, 2025
JK · Effective Jul 13, 2025
J9 · Effective Dec 12, 2021
JH · Effective Dec 12, 2021
JL · Effective Dec 12, 2021
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J15 · Effective Oct 5, 2015
J6 · Effective Dec 24, 2023
JK · Effective Dec 24, 2023
JE · Effective Jun 28, 2016
JF · Effective Jun 28, 2016
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JL · Effective Oct 1, 2024
J9 · Effective Oct 1, 2024
National · Effective Nov 9, 2023
National · Effective Mar 5, 2026
National · Effective Feb 5, 2026
National · Effective Nov 13, 2025
J5 · Effective Feb 5, 2026
JL · Effective Jan 1, 2026
National · Effective Nov 6, 2025
National · Effective Jan 1, 2026
National · Effective Oct 1, 2024
J6 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
J9 · Effective Jan 1, 2026
JL · Effective Oct 1, 2025
J9 · Effective Jan 1, 2025
National · Effective Apr 17, 2025
J6 · Effective Oct 1, 2024
National · Effective Mar 26, 2026
J6 · Effective Oct 1, 2024
National · Effective Mar 26, 2026
J6 · Effective Jan 1, 2026
J5 · Effective Jan 1, 2026
J9 · Effective Oct 1, 2025
National · Effective Jun 1, 2026
National · Effective Jun 1, 2026
National · Effective Apr 16, 2026
J5 · Effective Jun 1, 2026
J6 · Effective Nov 1, 2025
J6 · Effective Oct 1, 2024
| Vagus Nerve Stimulation | Feb 9, 2024 | Covered |
|---|
| Policy | Effective | Status of F20.0 |
|---|---|---|
| Outpatient Glycated Hemoglobin and Protein Testing | Jul 1, 2026 | Covered |
| Outpatient Laboratory-based Blood Glucose Testing | Jul 1, 2026 | Covered |